The Study of Gender Characteristics of Arterial Hypertension in the First and Second Stages
|
Daria Aleksandrovna Sapunova Department of Clinical Functional Diagnostics, Faculty of Medicine, A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, Moscow, Russia.
Ekaterina Sergeevna Kachenkova Department of Adaptology and Sports Training, Institute of Natural Science and Sports Technologies of the Moscow City Pedagogical University, Moscow, Russia.
Ilya Nikolaevich Medvedev* Faculty of Medicine, Russian State Social University, Moscow, Russia.
|
*E-mail: [email protected]
Abstract
To clarify gender differences in the status of patients suffering from stage 1 and 2 arterial hypertension, 80 patients of the second mature age suffering from arterial hypertension were examined. They were divided into 2 groups. The first included 44 patients with stage 1 arterial hypertension, and the second group included 36 patients with stage 2 of the disease. In both sexes, in the case of stage 1 arterial hypertension, the level of arterial pressure corresponds to stage 1. At stage 2, blood pressure values in men are at the level of 1 degree, and in women, they correspond to 2 degrees. The amounts of total cholesterol and cholesterol in the composition of low-density lipoproteins were above the normative level and prevailed in women of both groups. At the 1st stage of hypertension in women, there was a more pronounced imbalance in the amounts of thromboxane B2 and 6-keto-prostaglandin F1α, which was aggravated during the growth of the pathology stage. In men, glomerular filtration was preserved in both groups. From the very beginning of the disease in women, it was reduced, gradually worsening with the progression of the disease. The thickness of the vascular intima and copper in women already at stage 1 was higher than in men and increased with the severity of the pathology. It can be thought that in women, already during the formation of arterial hypertension, more obvious and rapidly developing negative changes in the body appear than in men.
Keywords: Arterial hypertension, Sex differences, Degrees of hypertension, Blood, Internal organs
Introduction
In the modern world, cardiovascular pathology remains the main factor in the onset of disability, disability, and early death (Crea et al., 2015; Bespalov et al., 2018). Arterial hypertension (AH) is one of the most common diseases in the world that affects the heart and blood vessels (Alismail et al., 2020). This pathology has recently been encountered more and more often in middle age and is considered a leading factor in the development of cardiovascular disorders (Karpov et al., 2020). The incidence of hypertension among residents of developed countries increases with increasing age. Middle-aged people have a 30% risk of arterial hypertension, while among people over 70 years of age, it is about 70% (Mills et al., 2016). The situation with AH is seriously aggravated by the fact that in the age structure of mortality from its complications, the prevalence of people of working age is traced (Fayzullina et al., 2020).
To the recommendations of the European Society of Cardiology / European Society of Hypertension, hemodynamic and metabolic changes, socioeconomic distress, and emotional overload are considered significant moments in the formation of arterial hypertension (Williams et al., 2018). The modern view of hypertension makes it necessary to seriously individualize the approach to its prevention and treatment (Alqahtani et al., 2021). This option of patient management is now considered the main one among many modern researchers, requiring it to take into account gender and individual characteristics (Minges et al., 2017).
Recent studies are beginning to focus on the presence of gender differences in cardiac patients, which were previously almost not taken into account (Al Zahrani et al., 2019). Much of the previous work has been done with only middle-aged men (Lee, 2017).
Undeniable facts are accumulating, pointing to differences between the sexes in the development of arterial hypertension, its course, and prognosis. A great vulnerability of the cardiovascular system was observed in the male part of the population (Karpov et al., 2021a). This is due to the high prevalence of arterial hypertension in mature men, often combined with overweight, smoking, and hypercholesterolemia (Jankauskiene & Baceviciene, 2019). For this reason, the first myocardial infarction in men is often recorded between 55 and 65 years of age, while among women it is recorded for the first time, usually at the age of 65-72 years (Kanic et al., 2016). Despite the importance of the problem of gender differences in hypertension, there are only a few studies devoted to the sexual characteristics of the development of hypertension, which dictates the need for in-depth research in this direction (Benjamin et al., 2017).
Objective
To trace gender differences in clinical and biochemical characteristics of patients suffering from hypertension in the first and second stages.
Materials and Methods
The work was performed at the clinical base of the Moscow State University of Medicine and Dentistry named after A. I. Evdokimov. All patients included in it, when taken under observation, gave voluntary informed written consent to their participation in the study. 80 patients of the second mature age (45-55 years) with confirmed hypertension were taken under observation, of which 44 patients had stage I hypertension and 36 patients had stage II disease.
Patients were divided into 2 groups according to their stage of AH. The first group with stage I AH included 11 men and 33 women. The second group with stage II arterial hypertension included 25 men and 11 women. Men and women of both groups were comparable in age. The criteria for inclusion in the study were the following signs: the presence of clinical manifestations of primary AH of I and II stages and the duration of hypertension for at least two years, the absence of concomitant diseases of the cardiovascular system, the absence of diabetes mellitus, the absence of acute forms or exacerbation of chronic inflammatory diseases, and the absence of cancer (Tati et al., 2021; Halimah et al., 2022).
The clinical examination of all patients consisted of clarifying complaints, determining a gynecological history in women, a clinical examination consisting of an assessment of blood pressure, pulse, height, body weight, waist and hips, calculation of the Quetelet index - [body weight (kg)/height (m²)]. In all cases, cholesterol levels were assessed; triglycerides; cholesterol included in lipoproteins having a high density; cholesterol included in lipoproteins having a low density; glucose; creatinine. In all those observed in plasma, by enzyme immunoassay using a kit manufactured by EnzoLifescience (USA), the amount of thromboxane B2 and 6-keto-prostaglandin F1α was recorded. Traditionally, the glomerular filtration rate was determined. In the course of Doppler ultrasonography, the thickness of the intima and media was determined in the wall of the common carotid artery (Elsheikh et al., 2020).
Statistical processing of the results of the study was carried out using the program Statistica 5.5. The arithmetic means and standard deviation (M±SD) were calculated for each indicator. The Student's t-test was used, and for paired comparisons of indicators within groups, the nonparametric Smirnov-Kolmogorov test was used. Differences were considered statistically significant at p<0.05.
Results and Discussion
The results of assessing the gender characteristics of the considered general indicators in patients suffering from stage 1 AH are presented in Table 1.
Table 1. General indicators of patients with AH of the first stage
|
Estimated indicators |
Men, n=11 |
Women, n=33 |
Standard values |
|
Age, years |
49.1±11.43 |
51.6±7.08 |
- |
|
Height, cm |
176.8±3.06 |
168.4±5.34 |
- |
|
The value of body weight, kg |
82.8±10.15 |
73.7±14.31* |
- |
|
Body mass index, kg/m2 |
26.5±3.16 |
27.3±4.64 |
<25 |
|
Waist, cm |
91.0±5.61 |
83.3±11.73 |
<102for men, <88 for women |
|
Hips, cm |
102.2±2.87 |
106.3±10.36 |
- |
|
Waist / Hip |
0.88±0.05 |
0.78±0.06* |
<0,9 for men, <0,85 for women |
|
Systolic blood pressure, mm Hg |
145.0±7.82 |
142.4±14.33 |
<140 |
|
Diastolic blood pressure, mm Hg |
98.0±6.32 |
93.4±10.49 |
<90 |
|
Pulse beats / minute |
68.2±7.96 |
78.4±10.71* |
<80 per min |
|
Glomerular filtration rate, ml / min / 1.73m² |
92.3±11.25 |
76.4±17.79* |
>90 |
|
Intima-media complex thickness, mm |
0.69±0.35 |
0.95±0.15 |
<0,9 |
Note: validity of differences between the sexes: * - p <0.05, ** - p <0.01. In the tables below the text, the designations are the same.
When comparing men and women suffering from stage 1 arterial hypertension by age and height, the comparability of the considered indicators was found. The body weight of men significantly exceeded the body weight of women in this group by 12.4%. At the same time, the body mass index in patients of different sexes in the group with stage 1 arterial hypertension did not differ. Their hips were comparable, and the waist tended to prevail in men. At the same time, the ratio of waist-to-hip volume in men significantly exceeded the same indicator in women by 12.8%.
The values of systolic and diastolic blood pressure were increased in both sexes to the level of arterial hypertension of the 1st degree with a certain tendency to prevail in men. At the same time, the pulse value in the group with stage 1 AH was 14.7% higher in women.
The glomerular filtration rate in patients with stage 1 AH demonstrated significant gender differences. In sick men, this indicator remained within the normal range. In women, it turned out to be reduced, yielding 20.8% less than the men’s level. The thickness of the vascular intima and media in female patients slightly exceeded the normative level and significantly prevailed over the value of this indicator in men (by 37.7%).
The level of total cholesterol in the blood of patients with the first stage of arterial hypertension in both sexes exceeded the standard values with a tendency to prevail in women (Table 2).
Table 2. Biochemical parameters of patients with AH of the first stage
|
Estimated indicators |
Men, n=11 |
Women, n=33 |
Standard values |
|
Total cholesterol, mmol/l |
5.48±0.79 |
5.68±0.91 |
<5 |
|
Triglycerides, mmol/l |
1.57±0.85 |
1.40±0.85 |
<1,7 |
|
The number of cholesterol lipoproteins with low density, mmol/l |
3.18±0.67 |
3.96±0.83** |
<3 |
|
High-density lipoprotein cholesterol, mmol/l |
1.43±0.41 |
1.48±0.42 |
<1,0 for men, <1,2 for women |
|
Glucose content, mmol/l |
5.29±0.93 |
5.19±0.70 |
≤5,5 |
|
Creatinine level, mmol/l |
84.4±8.11 |
79.2±18.54 |
<115 for men, <107 for women |
|
Thromboxane B2, pg/ml |
174.2±0.52 |
182.9±0.64 |
<160 |
|
6-keto prostaglandin F1α, pg/ml |
93.6±0.39 |
89.2±0.46 |
>95 |
The concentrations of triglycerides and cholesterol contained in high-density lipoproteins were comparable in patients of different sexes and were within the normal range. The amount of cholesterol in low-density lipoproteins in all patients was above the standard values.
At the same time, in women, its level was 24.5% higher than in men. The levels of glucose and creatinine in the observed patients remained within the normal range and had no gender differences. The concentrations of thromboxane and prostacyclin metabolites were outside the normative range. In the plasma of patients, the level of thromboxane B2 was above the norm, and the amount of 6-keto-prostaglandin F1α was inferior to the normative values. In women, their changes were somewhat more pronounced, forming a tendency towards a greater imbalance in the metabolites of arachidonic acid.
Gender characteristics of the considered general indicators of the group of patients suffering from stage 2 hypertension are presented in Table 3.
Table 3. Indicators of patients with arterial hypertension of the second stage
|
Estimated indicators |
Men, n=25 |
Women, n=11 |
Standard values |
|
Age, years |
49.7±5.52 |
54.8±6.31 |
- |
|
Height, cm |
175.2±4.98 |
164.6±3.91 |
- |
|
Body weight, kg |
85.5±11.55 |
84.2±9.62 |
- |
|
Body mass index value, kg/m² |
27.9±2.98 |
31.3±3.15* |
<25 |
|
The value of the waist, cm |
94.8±6.82 |
95.7±11.66 |
<102 for men, <88 for women |
|
Hips, cm |
102.4±4.87 |
113.1±9.49* |
- |
|
Waist/Hip Ratio |
0.93±0.07 |
0.85±0.05* |
<0,9 for men, <0,85 for women |
|
The value of systolic blood pressure, mm Hg. |
156.0±12.33 |
163.3±18.72 |
<140 |
|
The value of diastolic blood pressure, mm Hg. |
95.0±6.53 |
105.8±9.82* |
<90 |
|
Pulse, beats / minute |
66.5±9.05 |
68.8±7.09 |
<80 per min |
|
Glomerular filtration rate, ml / min / 1.73m² |
88.8±15.05 |
71.3±8.41** |
>90 |
|
Intima-media complex thickness, mm |
0.84±0.29 |
1.03±0.09** |
<0,9 |
When comparing men and women suffering from stage 2 AH by age, body weight, and height, no significant differences could be found. The value of the body mass index in women with stage 2 hypertension exceeded the level of men by 13.3%. Women's hips were 11.0% larger, and the waist was comparable across the sexes. At the same time, the ratio of waist to hips in men significantly exceeded that in women by 10.0%.
Among patients with stage 2 hypertension, systolic and diastolic blood pressure values were increased in men to the level of 1 degree, and in women to the values of 2 degrees. The pulse value in the group with stage 2 AH was within the normal range for both sexes.
The plasma content of total cholesterol in patients with stage 2 AH of both sexes exceeded the standard values with a significant prevalence in women (Table 4).
Table 4. Biochemical parameters of patients with second-stage hypertension
|
Estimated indicators |
Men, n=25 |
Women, n=11 |
Standard values |
|
Level of total cholesterol, mmol/l |
5.3±0.93 |
6.3±1.53* |
<5 |
|
Triglycerides, mmol/l |
1.36±0.98 |
1.49±0.38 |
<1,7 |
|
Cholesterol of lipoproteins with low density, mmol/l |
3.29±0.88 |
3.36±0.26 |
<3 |
|
High-density lipoprotein cholesterol, mmol/l |
1.23±0.34 |
1.31±0.27 |
<1,0 for men, <1,2 for women |
|
Glucose content, mmol/l |
5.28±0.49 |
5.19±0.47 |
≤5,5 |
|
Creatinine, mmol/l |
89.6±13.73 |
83.8±9.43 |
<115 for men, <107 for women |
|
The amount of thromboxane B2, pg/ml |
179.4±0.48 |
188.7±0.73 |
<160 |
|
Level of 6-keto-prostaglandin F1α, pg/ml |
90.8±0.35 |
83.6±0.42 |
>95 |
The concentrations of triglycerides and cholesterol found in high-density lipoproteins were comparable in patients of different sexes and were within the normal range. The content of low-density lipoprotein cholesterol in the blood was comparable to the normal level in patients of both sexes.
Blood glucose and creatinine concentrations in all patients with stage 2 AH were within the normal range and did not differ in different sexes. The levels of thromboxane and prostacyclin metabolites in all examined patients were beyond the normative values. In women, violations of their levels tended to be more pronounced, forming a tendency to a more pronounced imbalance in their blood of arachidonic acid metabolites.
The glomerular filtration rate in patients with stage 2 AH showed significant gender differences. In sick men, this indicator was slightly below the norm, while in women it was significantly reduced, yielding to the level of men by 25.0%. The thickness in the vessels of the intima and media in women with stage 2 AH exceeded the normative level and prevailed over the value of this indicator in men by 23.0%.
Various aspects of AH have been studied for a long time (Mehta et al., 2016). This is carried out both in the clinic and in the course of various experiments (Kotova et al., 2017; Karpov et al., 2021b). The main invariable risk factors for the development of hypertension are known - gender and age (Zavalishina et al., 2018). At the same time, most researchers note that the incidence of hypertension increases with increasing age (Mendelsohn & Karas, 2005). At the same time, the study of gender characteristics in the development and course of AH was started not so long ago. For the first time in the Framingham Heart Study, it was possible to find clear differences between hypertensive patients of different sexes. It is noticed that up to 50 years of age AH affects men more often. At an older age, the incidence of this disease increases in women, which is associated with an increase in the number of factors contributing to the development of hypertension in them (Liu et al., 2001; Stramba-Badiale et al., 2006).
The authors of this work found that in hypertensive patients with stage 1 AH in men, by the age of 49 years, higher numbers of systolic and diastolic blood pressure began to be noted compared to women. Their mean age of manifestation of hypertension was 51 years. The average age of registration for stage 2 AH in women was about 55 years. In hypertensive men, this age was 50 years. At the same time, in AH of the second stage, the blood pressure figures were higher in the female part of the observation group.
Being overweight and especially obese are strongly associated with an increased risk of numerous pathological conditions, including dyslipidemia, type 2 diabetes mellitus, metabolic syndrome, and focal segmental glomerulosclerosis (Aleksandrovna & Zavalishina, 2017). The authors noted that in patients with the first stage of AH in both sexes, there was a tendency to increase the body mass index. In women with the second stage of AH, the body mass index reached 30, while in men this indicator remained practically unchanged. The data obtained can be explained by hormonal changes in the body of a woman, which can increase the amount of body weight, leading to the appearance of abdominal obesity (Gallego et al., 2015; Karvonen-Gutierrez & Kim, 2016).
Metabolic risk factors for the occurrence of cardiovascular and metabolic disorders are recorded much more often in hypertension than in normatonic patients. Researchers have recently placed particular emphasis on waist circumference and waist-to-hip ratio, with less emphasis on body mass index. These indicators can more accurately indicate the appearance of abdominal obesity (Zavalishina, 2020). The authors found that in the case of the first stage of AH in both sexes, the waist volume remained within the normal range. However, in the course of the observation, it was noted that the ratio of the waist to the volume of the hips turned out to be greater in men, going beyond the normal range. In women with stage 2 AH, the waist volume and the ratio of waist to the hip volume were more than normal. In males, the average values of waist volume were not greater than the threshold values. The value of the ratio of the volume of the waist to the volume of the hips did not exceed the normative level but was less than this value in women. The information obtained does not contradict the available information that with an increase in blood pressure, the ratio of waist volume to hip volume increases (Minges et al., 2017).
Earlier work revealed that there is an undoubted connection between the increase in the concentration of triglycerides, total cholesterol, low-density lipoprotein cholesterol, and the risk of atherosclerosis manifestation. For the blood level of high-density lipoprotein cholesterol, this relationship is negative (Williams et al., 2018). The authors were able to show the comparability of total cholesterol levels in patients of both sexes with the first and second stages of AH. At the same time, all found concentrations of total cholesterol were above the normative level. Triglyceride concentrations showed a different pattern. Their average levels in patients of both sexes with the first and second stages of AH were within the generally accepted norm
When analyzing data on the level of low-density lipoprotein cholesterol, in the group with AH of the first stage, women showed a significantly higher content than men. In the second stage of AH, no differences in atherogenic low-density lipoprotein cholesterol were found between the sexes. The modern concept of the mechanism of atherosclerotic plaque formation in accordance with the lipid-infiltration theory assumes the entry into the subendothelial space of native and oxidized molecules, low-density lipoproteins. Moreover, the higher their level in the blood, the more intensively this process always proceeds (Zavalishina et al., 2021a). Consequently, women are highly susceptible to the rapid progression of atherosclerosis in the formation of hypertension.
In the work carried out in patients with the first stage of AH, a comparable concentration of high-density lipoprotein cholesterol in men and women was determined. In the group observed with hypertension in the second stage, no significant differences were also obtained. The level in patients with the second stage of AH was lower than in the first stage but did not decrease to the threshold level for high-density lipoprotein cholesterol.
In terms of glucose, the reliability of gender differences was not obtained in patients with the first stage of AH and patients with the second stage of AH. This indicates the maintenance of carbohydrate metabolism at a normal level in all examined patients.
When assessing the glomerular filtration rate, it was possible to obtain the reliability of the differences in this indicator between the sexes in both comparison groups. Mean values in men were significantly higher in the first stage of AH and in the second stage of AH. This allows us to say that women with hypertension are prone to earlier development of chronic kidney disease. It is known that estrogen has an antiproliferative effect on smooth muscle cells, and progesterone lowers the tone of arterioles and reduces sodium resorption in the renal tubules, thereby exerting an anti-mineralocorticoid effect. The loss of the optimal level of these hormones in postmenopausal women inevitably leads to the deterioration of renal function (Hodis et al., 2003; Zavalishina et al., 2021b).
At the same time, more pronounced disturbances in the synthesis of biologically important substances that can stimulate the aggregation of blood cells were noted in women with hypertension in platelets and vessel walls. In women with AH, the level of blood proaggregants pronouncedly increased as the disease progressed compared to the men. The greater intensification of thromboxane synthesis that develops in women, combined with a greater weakening of the formation of a substance with the opposite effect - prostacyclin, creates a more pronounced imbalance in the plasma between the activity of antiplatelet agents and substances - proaggregants. It can be thought that the violation of the ratio of arachidonate derivatives, which is created in AH, creates more pronounced conditions for microrheological disorders in women, starting from stage 1 of AH.
According to the definition of the World Health Organization, atherosclerosis is called "a variable combination of changes in the intima of the arteries, including the accumulation of lipids, lipoproteins, complex carbohydrates, fibrous tissue, blood components, calcification in the middle membrane of the vascular wall." It is recognized that in the walls of the arteries in patients with hypertension under the influence of pressure loading, there is a gradual increase in the thickness of the intima and media of the vessels, associated with the progression of atherosclerosis (Finn et al., 2010). According to the known data on the presence of asymptomatic target organ lesions in AH, it is appropriate to speak about the presence of subclinical atherosclerosis in a patient with AH (thickness of the intima/media complex> 0.9 mm) (Zavalishina et al., 2021c).
The world medical science recognizes the presence of gender differences in the formation of atherosclerotic vascular lesions, caused, first of all, by the peculiarities of the influence of the existing endocrine profile on the body (Monleiro, 2005). Estrogens slow down the remodeling of large arteries and inhibit the accumulation of foam cells in the vascular wall. They are also able to reduce the stiffness of the arterial wall and the magnitude of arterial systolic pressure by relaxing smooth myocytes in the walls of blood vessels. Progesterone also lowers the tone of arterioles and inhibits the proliferation of smooth muscle coronary arteries due to the blockade of slow calcium channels in their walls (Bots et al., 1994; Bonithon-Kopp et al., 1996).
In the study, men with the first stage of AH showed significantly lower values of the part of the intima-media of the vessels compared with women with stage 1 AH. In the group with AH of the second stage, men again demonstrated a significantly lower value of the intima-media complex index than women. The data obtained are consistent with previously published works, where in premenopausal patients a positive relationship was found between an increase in the thickness of the intima-media complex of the carotid common artery and an increase in the level of pulse pressure, triglyceride levels, body mass index, and age (Fröhlich et al., 2004; Zavalishina, 2021d). Thus, according to the information found in our study, it can be assumed that the examined men do not have, and the women taken under observation have subclinical atherosclerosis.
Considering the state of metabolic parameters in patients with hypertension, one can think that they had excessive body mass indices, indicating the presence of obesity in combination with lipid metabolism disorders to the level of atherogenic dyslipidemia (Lobo, 2017; Zavalishina et al., 2021e). Changes in metabolism are already present at the onset of arterial hypertension in women. This is consistent with the point of view of a decrease in the severity of the cardioprotective effect of estrogens during premenopause (Mikhaylova et al., 2021; Zavalishina et al., 2022).
Conclusion
Arterial hypertension is a very common disease globally. The prevalence of hypertension increases with age. Its presence always aggravates the work of the cardiovascular system, accelerating the development of atherosclerosis. Worldwide, hypertension is an important factor in disability, disability, and death in patients of both sexes. Taking into account sex differences makes it possible to reveal the gender characteristics of the values of pathogenetically significant indicators in patients with arterial hypertension. There is reason to believe that from the very beginning of the development of AH in women, more pronounced and more rapidly progressive lipid, hemostatic, and renal disorders occur in comparison with men. This significantly worsens their prognosis and requires more attention from clinicians for women with hypertension.
Acknowledgments: The team of authors thanks the administration of the Moscow City Pedagogical University, Institute of Natural Sciences and Sports Technology for the opportunity to research its basis.
Conflict of interest: None
Financial support: None
Ethics statement: The research was approved by the Ethics Committee of Moscow City Pedagogical University, Institute of Natural Sciences and Sports Technologies (record №10 from 11.10.2017).
Al Zahrani, S., Eid Alosaimi, M., Alamrim, A. A., Alotaibi, M., Almatar, E. A., & Almanea, B. A. (2019). Association between knowledge and drug adherence in patients with hypertension in Saudi Arabia. Archives of Pharmacy Practice, 10(3), 71-76.
Aleksandrovna, S., & Zavalishina, S. Y. (2017). Ability to aggregation of basic regular blood elements of patients with hypertension and dyslipidemia receiving non-medication and simvastatin. Bali Medical Journal, 6(3), 521-528. doi:10.15562/bmj.v6i3.553
Alismail, A. I., Alosaimi, W. A., Faqihi, A. Y., Al-Sahagi, R. J. N., Alfraiji, A. F., Aloofy, O. A., Alhaidar, S. M., Alfaifi, A. A., Alrasheed, M. S., & Alkhurayb, N. T. (2020). Hypertension Diagnosis and Management Approach. International Journal of Pharmaceutical Research & Allied Sciences, 9(1), 84-88.
Alqahtani, M. M. B., Islam, A. F., Katib, G. A., Islam, L. F., Abdulmohsen, A., Alhaddab, H. Y. A., Alqattan, H. S., Ahmad, A. A., Albogami, M. M. O., Alsalhi, S., et al. (2021). An Overview on Hypertension: Management Approach and Follow Up in Primary Health Care Center. Archives of Pharmacy Practice, 12(3), 110-112.
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., De Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017). Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation, 135(10), 146-156. doi:10.1161/ CIR.0000000000000485
Bespalov, D. V., Kharitonov, E. L., Zavalishina, S. Y., Mal, G. S., & Makurina, O. N. (2018). Physiological basis for the distribution of functions in the cerebral cortex. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 9(5), 605-612.
Bonithon-Kopp, C., Touboul, P. J., Berr, C., Leroux, C., Mainard, F., Courbon, D., & Ducimetière, P. (1996). Relation of intima-media thickness to atherosclerotic plaques in carotid arteries: the Vascular Aging (EVA) Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 16(2), 310-316. doi:10.1161/01.ATV.16.2.310
Bots, M. L., Hofman, A., & Grobbee, D. E. (1994). Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 14(12), 1885-1891. doi:10.1161/01.atv.14.12.1885
Crea, F., Battipaglia, I., & Andreotti, F. (2015). Sex differences in mechanisms, presentation and management of ischaemic heart disease. Atherosclerosis, 241(1), 157-168. doi:10.1016/j.atherosclerosis.2015.04.802
Elsheikh, A. M., Teama, M. I., Afify, A. F., Abowarda, M. H., & Almassry, H. N. (2020). Comparative study between conventional trans-arterial chemoembolization (TACE) and drug eluting bead TACE regarding tumour response and liver function tests. Archives of Pharmacy Practice, 11(1), 153-162.
Fayzullina, I. I., Savchenko, D. V., Makurina, O. N., Mal, G. S., Kachenkova, E. S., & Lazurina, L. P. (2020). Improving the level of socio-psychological adaptation in first-year students of a Russian university Moscow, Russia. Bioscience Biotechnology Research Communications, 13(3), 1231-1235.
Finn, A. V., Kolodgie, F. D., & Virmani, R. (2010). Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(2), 177-181. doi:10.1161/ATVBAHA.108.173609
Fröhlich, M., Albermann, N., Sauer, A., Walter-Sack, I., Haefeli, W. E., & Weiss, J. (2004). In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins. Biochemical Pharmacology, 68(12), 2409-2416. doi:10.1016/j.bcp.2004.08.026
Gallego, M. P. O., López, P. B., Armero, M. A. T., Alemán, J. A., Albero, J. S., & López, P. J. T. (2015). Metabolic syndrome and its components in Spanish postmenopausal women. Nutricion Hospitalaria, 32(2), 656-666. doi:10.3305/nh.2015.32.2.9211
Halimah, E., Hendriani, R., Indradi, B., & Sofian, F. F. (2022). Cytotoxicity of ethanol extract and its fractions from Acalypha wilkesiana against breast cancer cell MCF-7. Journal of Advanced Pharmacy Education & Research, 12(1), 17-20.
Hodis, H. N., Mack, W. J., Azen, S. P., Lobo, R. A., Shoupe, D., Mahrer, P. R., Faxon, D. P., Cashin-Hemphill, L., Sanmarco, M. E., French, W. J., et al. (2003). Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. New England Journal of Medicine, 349(6), 535-545. doi:10.1056/NEJMoa030830
Jankauskiene, R., & Baceviciene, M. (2019). Body image concerns and body weight overestimation do not promote healthy behaviour: evidence from adolescents in Lithuania. International Journal of Environmental Research and Public Health, 16(5), 864. doi:10.3390/ijerph16050864
Kanic, V., Vollrath, M., Naji, F. H., & Sinkovic, A. (2016). Gender related survival differences in ST-elevation myocardial infarction patients treated with primary PCI. International Journal of Medical Sciences, 13(6), 440-444. doi:10.7150/ijms.15214
Karpov, V. Y., Zavalishina, S. Y., Bakulina, E. D., Dorontsev, A. V., Gusev, A. V., Fedorova, T. Y., & Okolelova, V. A. (2021b). The physiological response of the body to low temperatures. Journal of Biochemical Technology, 12(1), 27-31. doi:10.51847/m1aah69aPr
Karpov, V. Y., Zavalishina, S. Y., Komarov, M. N., & Koziakov, R. V. (2020). The potential of health tourism regarding stimulation of functional capabilities of the cardiovascular system. Bioscience Biotechnology Research Communications, 13(1), 156-159. doi:10.21786/bbrc/13.1/28
Karpov, V. Y., Zavalishina, S. Y., Marinina, N. N., Skorosov, K. K., Kumantsova, E. S., & Belyakova, E. V. (2021a). Possibilities of regular physical culture lessons in restoring the functional status of students. Journal of Biochemical Technology, 12(2), 62-66. https://jbiochemtech.com/wDCYQLtIxh
Karvonen-Gutierrez, C., & Kim, C. (2016). Association of mid-life changes in body size, body composition and obesity status with the menopausal transition. Healthcare (Basel), 4(3), 1-16. doi:10.3390/healthcare4030042
Kotova, O. V., Zavalishina, S. Yu., Makurina, O. N., Kiperman, Ya. V., Savchenko, A. P., Skoblikova, T. V., Skripleva, E. V., Zacepin, V. I., Skriplev, A. V., & Andreeva, V. Yu. (2017). Impact estimation of long regular exercise on hemostasis and blood rheological features of patients with incipient hypertension. Bali Medical Journal, 6(3), 514-520. doi:10.15562/bmj.v6i3.552
Lee, Y. (2017). Slender women and overweight men: gender differences in the educational gradient in body weight in South Korea. International Journal for Equity in Health, 16(1), 1-18. doi:10.1186/s12939-017-0685-9
Liu, Y., Ding, J., Bush, T. L., Longenecker, J. C., Nieto, F. J., Golden, S. H., & Szklo, M. (2001). Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. American Journal of Epidemiology, 154(6), 489-494. doi:10.1093/aje/154.6.489
Lobo, R. A. (2017). Hormone-replacement therapy: current thinking. Nature Reviews Endocrinology, 13(4), 220-231. doi:10.1038/nrendo.2016.164
Mehta, L. S., Beckie, T. M., DeVon, H. A., Grines, C. L., Krumholz, H. M., Johnson, M. N., Lindley, K. J., Vaccarino, V., Wang, T. Y., Watson, K. E., et al. (2016). Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation, 133(9), 916-947. doi:10.1161/ CIR.0000000000000351
Mendelsohn, M. E., & Karas, R. H. (2005). Molecular and cellular basis of cardiovascular gender differences. Science, 308(5728), 1583-1587. doi:10.1126/science.1112062
Mikhaylova, I. V., Zavalishina, S. Y., Vladimirovna, Y., Zbrueva, E. D. B., Rysakova, O. G., & Viktorovich, M. (2021). Dynamics of general functional characteristics of an individual in the process of chess training. Journal of Biochemical Technology, 12(4), 61-66. doi:10.51847/a7DmaeQ9UD
Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016). Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation, 134(6), 441-450. doi:10.1161/CIRCULATIONAHA.115.018912
Minges, K. E., Strait, K. M., Owen, N., Dunstan, D. W., Camhi, S. M., Lichtman, J., Geda, M., Dreyer, R. P., Bueno, H., Beltrame, J. F., et al. (2017). Gender differences in physical activity following acute myocardial infarction in adults: a prospective, observational study. European Journal of Preventive Cardiology, 24(2), 192-203. doi:10.1177/2047487316679905
Monleiro, P. P. (2005) Gender influences on coronary disease. European Heart Journal, 26, 217.
Stramba-Badiale, M., Fox, K. M., Priori, S. G., Collins, P., Daly, C., Graham, I., Jonsson, B., Schenck-Gustafsson, K., & Tendera, M. (2006). Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. European Heart Journal, 27(8), 994-1005. doi:10.1093/eurheartj/ehi819
Tati, S., Nurul Fatimah, N., Yandri, Y., Rahmat Kurniawan, R., Syaiful, B., & Sutopo, H. (2021). The anticancer, antimalarial, and antibacterial activities of moracalkon a isolated from Artocarpus kemando Miq. Journal of Advanced Pharmacy Education & Research, 11(4), 105-110.
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., De Simone, G., Dominiczak, A., et al. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal, 39(33), 3021-3104. doi:10.1093/eurheartj/ehy339
Zavalishina, S. Y. (2020). Functional activity of the cardiorespiratory system and the general level of physical capabilities against the background of regular physical exertion. Bioscience Biotechnology Research Communications, 13(4), 2327-2331. doi:10.21786/bbrc/13.4/105
Zavalishina, S. Y., Bakulina, E. D., Eremin, M. V., Kumantsova, E. S., Dorontsev, A. V., & Petina, E. S. (2021a). Functional changes in the human body in the model of acute respiratory infection. Journal of Biochemical Technology, 12(1), 22-26. doi:10.51847/F8mofsugnZ
Zavalishina, S. Y., Karpov, V. Y., Bakulina, E. D., Rysakova, O. G., Tagirova, N. D., & Sibgatulina, F. R. (2021e). The Function of Maintaining Body Balance in Students Involved in Various Sports. Journal of Biochemical Technology, 12(4), 94-98. doi:10.51847/bnyZig6kjI
Zavalishina, S. Y., Karpov, V. Y., Bakulina, E. D., Rysakova, O. G., Tagirova, N. D., & Sibgatulina, F. R. (2021b). The Function of Maintaining Body Balance in Students Involved in Various Sports. Journal of Biochemical Technology, 12(4), 94-98. doi:10.51847/bnyZig6kjI
Zavalishina, S. Y., Karpov, V. Y., Rysakova, O. G., Rodionov, I. A., Pryanikova, N. G., & Shulgin, A. M. (2021c). Physiological reaction of the body of students to regular physical activity. Journal of Biochemical Technology, 12(2), 44-47. doi:10.51847/ERJ8YmdKPC
Zavalishina, S. Y., Karpov, V. Y., Zagorodnikova, A. Y., Ryazantsev, A. A., Alikhojin, R. R., & Voronova, N. N. (2021d). Functional mechanisms for maintaining posture in humans during ontogenesis. Journal of Biochemical Technology, 12(1), 36-39. doi:10.51847/5LNdtyTcdH
Zavalishina, S. Y., Shalupin, V. I., Rodionova, I. A., Kumantsova, E. S., Rysakova, O. G., Ryazantsev, A. A., & Sibgatulina, F. R. (2022). Influence of Regular Basketball Practice in Adolescence on the Functional Capacity of the Heart. Journal of Biochemical Technology, 13(1), 20-24. doi:10.51847/WOUcyQNmHe
Zavalishina, S., Makurina, O. N., Vorobyeva, N. V., Mal, G. S., & Glagoleva, T. I. (2018). Physiological features of surface properties of the erythrocyte membrane in newborn piglets. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 9(4), 34-38.